ArticleBlood advances2026

Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

John Sharp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.